Cannabidiol or CBD, the offspring of the Cannabis Sativa has become a monumental cash crop. Not to be confused with tetrahydrocannabinol or THC, the active ingredient in Cannabis Sativa that ushers the “high” people experience. The Cannabis Sativa plant was used for medicine and rituals as early as 750 B.C. in Central Asia. Believed to relieve ailments from post-traumatic stress syndrome to drug-resistant epilepsy, Cannabidiol companies dove into manufacturing anything possible containing CBD for use on humans and pets alike. Although these claims are not substantiated, anyone that has used either cannabinoid swears to their benefits.
Certificate Program To Train CBD Professionals
With the massive take-off of CBD, there is a shortage of knowledgeable professionals to inform consumers of the uses and benefits of Cannabidiol-infused products. The newly launched CBD Certificate Program through Green Flower Media instructs individuals on the goals as entrepreneurs and covers topics related to the CBD industry. The program includes courses on customer guidance, state and federal regulatory policies, consumer goods, marketing concepts, therapeutic benefits of CBD, comprehending state, and federal regulations.
CBD Goes Public On Canadian Securities Exchange
CanaFarma Corp, whose chief product is a CBD infused gum, jumped into the CBD game last year and became a publicly-traded entity. The company has come out on top having its own processing facility, research, and marketing staff. Strictly Cannabis companies have been stuck in a regulatory holding pattern where marijuana is concerned. Those same companies shelved the Cannabis Sativa regulatory process and moved over to CBD production, realizing the CanaFarma Corps 2020 projection of 45 million in revenue. Many CBD start-ups took CanaFarm Corp’s lead and quickly moved forward in the production of CBD to get a piece of the action. When several companies compete on the same Cannabidiol products, it means a more significant variety and lower prices.
The CBD Industry Is Big Business Not A Fad
Although research is thin, CBD now a 1 billion dollar industry, is compounded into many products from coffee to shampoo. Companies slowly realize CBD is more than just a fad. A groundbreaking cannabidiol infused drug brought hope to kids with various seizure disorders. Parents claim they gave their 6-month-old son going through the hell of chemotherapy for a form of eye cancer, a drop of CBD oil to stop his vomiting. This particular story made an appearance at the Tribeca Film Festival in 2019 via a documentary called Waldo on Weed, produced by Whoopie Goldberg.
The Federal Drug Administration Gets On Board With CBD
Last year a purified 100% CBD extract called Epidiolex was approved by the Federal Drug Administration for a seizure disorder. Reports elude to more FDA approvals for other product forms of CBD coming down the pipeline. While most approvals hang in the balance, despite positive effects in trials, consumers have taken it on themselves to use one cannabidiol compound or another. They are taking CBD for off-label treatments regarding medical issues such as post-traumatic stress disorder, generalized social anxiety, sleep disorders, depression, chronic pain, and many more. Doctors report that when consumers use CBD without guidance, it’s hazardous due to some forms containing dextromethorphan or DXM and synthetic cannabinoids, also known as Spice.
CBD Infused Products From Ice Cream To Skincare
One of the most popular ice cream company, Ben and Jerry’s, is getting ready to launch CBD infused ice cream as soon as its FDA approved. Ben and Jerry’s company is also harkening a call to action for support in legalizing CBD, not only in ice cream but many other forms of CBD infused products. This coming week shows promise as the Federal Drug Administration will hold their first hearing on legalizing CBD infused food and beverages.